New hope for wet AMD patients: a simple pill may drain stubborn eye fluid
NCT ID NCT04504123
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an oral medication (doxycycline) can help people with wet age-related macular degeneration (AMD) who still have fluid under their retina despite standard eye injections. About 50 participants will receive either doxycycline or a placebo for several months. The main goal is to see if the pill can clear the fluid and reduce the need for injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXUDATIVE MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa Hospitals & Clinics Department of Ophthalmology & Visual Sciences
RECRUITINGIowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could eye drops replace injections for a leading cause of blindness?
- Eye injection burden varies by disease, study finds
- Gene therapy could end frequent eye injections for wet AMD
- Gene therapy for wet AMD: could this mean fewer eye injections?
- New eye drug shows promise in battle against blinding disease
- Elderly AMD patients to test Easy-to-Use home vision tracker